FI59812C - Foerfarande foer isolering av en ny rabiesvirusstam - Google Patents
Foerfarande foer isolering av en ny rabiesvirusstam Download PDFInfo
- Publication number
- FI59812C FI59812C FI780184A FI780184A FI59812C FI 59812 C FI59812 C FI 59812C FI 780184 A FI780184 A FI 780184A FI 780184 A FI780184 A FI 780184A FI 59812 C FI59812 C FI 59812C
- Authority
- FI
- Finland
- Prior art keywords
- virus
- rabies
- vaccine
- hep
- virus strain
- Prior art date
Links
- 241000700605 Viruses Species 0.000 abstract description 39
- 229960005486 vaccine Drugs 0.000 abstract description 17
- 206010037742 Rabies Diseases 0.000 abstract description 13
- 241001465754 Metazoa Species 0.000 abstract description 9
- 241000711798 Rabies lyssavirus Species 0.000 abstract description 9
- 210000004027 cell Anatomy 0.000 abstract description 8
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 2
- 241000894007 species Species 0.000 abstract description 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 11
- 238000002255 vaccination Methods 0.000 description 9
- 238000011081 inoculation Methods 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000007918 pathogenicity Effects 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 4
- 210000003837 chick embryo Anatomy 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 230000000120 cytopathologic effect Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 229960003127 rabies vaccine Drugs 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 230000024932 T cell mediated immunity Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000001325 yolk sac Anatomy 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000007919 viral pathogenicity Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI800539A FI61626C (fi) | 1977-01-26 | 1980-02-22 | Foerfarande foer framstaellning av nya rabiesvirusvaccin |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB325877 | 1977-01-26 | ||
| GB3258/77A GB1596653A (en) | 1977-01-26 | 1977-01-26 | Vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI780184A FI780184A (fi) | 1978-07-27 |
| FI59812B FI59812B (fi) | 1981-06-30 |
| FI59812C true FI59812C (fi) | 1981-10-12 |
Family
ID=9754946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI780184A FI59812C (fi) | 1977-01-26 | 1978-01-20 | Foerfarande foer isolering av en ny rabiesvirusstam |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4320115A (it) |
| JP (2) | JPS5394084A (it) |
| AT (1) | AT368005B (it) |
| BE (1) | BE863368A (it) |
| CA (1) | CA1112167A (it) |
| CH (2) | CH659084A5 (it) |
| DE (1) | DE2803240B2 (it) |
| DK (1) | DK36378A (it) |
| ES (2) | ES466359A1 (it) |
| FI (1) | FI59812C (it) |
| FR (1) | FR2378859B1 (it) |
| GB (1) | GB1596653A (it) |
| IE (1) | IE46498B1 (it) |
| IT (1) | IT1192756B (it) |
| LU (1) | LU78951A1 (it) |
| NL (1) | NL174371C (it) |
| NO (1) | NO780156L (it) |
| PT (1) | PT67554B (it) |
| SE (2) | SE444453B (it) |
| ZA (1) | ZA78421B (it) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4347239A (en) | 1980-07-30 | 1982-08-31 | Norden Laboratories, Inc. | Inactivated rabies vaccine for veterinary use |
| US4429045A (en) | 1980-07-30 | 1984-01-31 | Norden Laboratories, Inc. | Rabies virus adapted for growth in swine testicle cell culture |
| EP0100752A3 (de) * | 1982-08-04 | 1985-04-17 | Veterinär-Bakteriologisches Institut der Universität Bern | Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung |
| JPS6147187A (ja) * | 1984-08-10 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 狂犬病ウイルスの精製方法 |
| DE3526809A1 (de) * | 1985-07-26 | 1987-04-02 | Behringwerke Ag | Tollwut-lebendimpfstoff |
| CA1249518A (en) * | 1985-09-06 | 1989-01-31 | David Johnston | Oral immunization of mammals |
| US7094391B1 (en) * | 1988-10-24 | 2006-08-22 | The University Of Texas System | Compositions and methods for administering Borrelia burgdorferi antigens |
| WO1995028175A1 (en) * | 1994-04-19 | 1995-10-26 | Thomas Jefferson University | Viral ribonucleocapsid as an immunological enhancer |
| US6495360B1 (en) * | 1999-05-28 | 2002-12-17 | Photogen, Inc. | Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| US20030118628A1 (en) * | 2001-04-05 | 2003-06-26 | Tutuncu Nurhan Pinar | Confectionery product having a salivation region and an oral comfort region |
| CN112342185B (zh) * | 2020-11-11 | 2022-12-02 | 深圳市卫光生物制品股份有限公司 | 一种鸡胚细胞狂犬病病毒的生物反应器工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1015262A (en) * | 1962-02-09 | 1965-12-31 | Nat Res Dev | Virus culture |
| US3255080A (en) * | 1962-08-06 | 1966-06-07 | Dow Chemical Co | Live rabies virus vaccine and method for the production thereof |
| US3397267A (en) * | 1964-09-21 | 1968-08-13 | Research Corp | Method of producing rabies vaccine |
| FR1567869A (it) * | 1967-06-22 | 1969-05-23 | ||
| US4014991A (en) * | 1976-01-23 | 1977-03-29 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Oral rabies immunization of carnivores |
-
1977
- 1977-01-26 GB GB3258/77A patent/GB1596653A/en not_active Expired
-
1978
- 1978-01-16 NO NO780156A patent/NO780156L/no unknown
- 1978-01-20 PT PT67554A patent/PT67554B/pt unknown
- 1978-01-20 NL NLAANVRAGE7800708,A patent/NL174371C/xx not_active IP Right Cessation
- 1978-01-20 FI FI780184A patent/FI59812C/fi not_active IP Right Cessation
- 1978-01-23 SE SE7800781A patent/SE444453B/sv not_active IP Right Cessation
- 1978-01-24 ZA ZA00780421A patent/ZA78421B/xx unknown
- 1978-01-24 IE IE161/78A patent/IE46498B1/en not_active IP Right Cessation
- 1978-01-24 CA CA295,550A patent/CA1112167A/en not_active Expired
- 1978-01-25 CH CH1456/86A patent/CH659084A5/de not_active IP Right Cessation
- 1978-01-25 DE DE2803240A patent/DE2803240B2/de not_active Withdrawn
- 1978-01-25 US US05/872,056 patent/US4320115A/en not_active Expired - Lifetime
- 1978-01-25 DK DK36378A patent/DK36378A/da not_active Application Discontinuation
- 1978-01-25 CH CH825/78A patent/CH658192A5/de not_active IP Right Cessation
- 1978-01-25 JP JP715078A patent/JPS5394084A/ja active Granted
- 1978-01-25 AT AT0052678A patent/AT368005B/de not_active IP Right Cessation
- 1978-01-25 IT IT67143/78A patent/IT1192756B/it active
- 1978-01-26 BE BE184675A patent/BE863368A/xx not_active IP Right Cessation
- 1978-01-26 ES ES466359A patent/ES466359A1/es not_active Expired
- 1978-01-26 LU LU78951A patent/LU78951A1/xx unknown
- 1978-01-26 FR FR7802215A patent/FR2378859B1/fr not_active Expired
- 1978-05-17 ES ES469937A patent/ES469937A1/es not_active Expired
-
1981
- 1981-10-13 US US06/310,447 patent/US4400472A/en not_active Expired - Fee Related
-
1982
- 1982-03-19 SE SE8201768A patent/SE443924B/sv not_active IP Right Cessation
- 1982-10-15 JP JP57181202A patent/JPS5877822A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dean et al. | Pathogenesis of rabies | |
| Nakajima et al. | Vaccination against red sea bream iridoviral disease in red sea bream | |
| Lucin et al. | Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands | |
| DE60012042T2 (de) | Entepneumovirus und entsprechendes impfstoff | |
| FI59812C (fi) | Foerfarande foer isolering av en ny rabiesvirusstam | |
| CN103525776A (zh) | 一种重组狂犬病病毒口服疫苗株及其制备方法 | |
| NZ244361A (en) | Chicken anaemia agent (caa) virus and vaccine | |
| EP0125245B1 (en) | Propagation of hemorrhagic enteritis virus in a turkey cell line | |
| ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
| KR100540856B1 (ko) | 뉴우캐슬병에 대한 난내 백신접종 | |
| Van der Heide et al. | Pathogenicity for chickens of a reovirus isolated from turkeys | |
| Nowotny et al. | Neuropathogenicity for suckling mice of equine herpesvirus 1 from the Lipizzan outbreak 1983 and of selected other EHV 1 strains | |
| Awad et al. | Preliminary studies of a newly developed subunit vaccine for channel catfish virus disease | |
| Motha | Effects of reticuloendotheliosis virus on the response of chickens to infectious laryngotracheitis virus | |
| EP0687471A1 (en) | Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture | |
| FI61626C (fi) | Foerfarande foer framstaellning av nya rabiesvirusvaccin | |
| Motha et al. | Outbreak of atypical fowlpox in chickens with persistent reticuloendotheliosis viraemia | |
| Powell | Protection against the JMV Marek's disease‐derived transplantable tumour by Marek's disease virus‐specific antigens | |
| McNeilly et al. | In vitro infection of mononuclear cells derived from various chicken lymphoid tissues by chicken anaemia virus | |
| Kaleta et al. | Persistent viraemia of a cell‐associated herpesvirus in white storks (Ciconia ciconia) | |
| EP0210552B1 (de) | Tollwut-Lebendimpfstoff | |
| Pépin et al. | Oral immunization against rabies with an avirulent mutant of the CVS strain: evaluation of its efficacy in fox (Vulpes vulpes) and its infectivity in seven other species | |
| Williams et al. | Pathogenicity of latent infectious laryngotracheitis virus in chickens | |
| AT368696B (de) | Verfahren zur gewinnung eines tollwutvirus | |
| Lee et al. | Isolation and identification of infectious pancreatic necrosis virus form rainbow trout cultured in Korea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: GIST-BROCADES N.V. |